2-Phenylethynyl-butyltellurium enhances learning and memory impaired by scopolamine in mice

Behavioural Pharmacology

Volumn 24, Issue 4, 2013, Pages 249-254

  Souza, Ana Cristina G ^a   Bruning, César A ^a   Acker, Carmine I ^a   Neto, José S S ^a   Nogueira, Cristina W ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Inhibitory avoidance; Memory; Morris water maze; Mouse; Organotellurium; Scopolamine; Tellurium

Indexed keywords

2 PHENYLETHYNYL BUTYLTELLURIUM; SCOPOLAMINE; TELLURIUM DERIVATIVE; UNCLASSIFIED DRUG; WATER;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; LATENT PERIOD; LEARNING DISORDER; LOCOMOTION; LONG TERM MEMORY; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; TASK PERFORMANCE; TRAINING;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; CARBON ISOTOPES; CHOLINERGIC ANTAGONISTS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MOTOR ACTIVITY; ORGANOMETALLIC COMPOUNDS; REACTION TIME; SCOPOLAMINE HYDROBROMIDE; TRITIUM;

EID: 84880578333     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32836353a5     Document Type: Article

References (43)

1. Aigner TG (1995). Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5:155-160.
2. Avila DS, Benedetto A, Au C, Manarin F, Erikson K, Soares FA, et al. (2012). Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress. Free Radic Biol Med 52:1903-1910.
3. Azizi Z, Ebrahimi S, Saadatfar E, Kamalinejad M, Majlessi N (2012). Cognitiveenhancing activity of thymol and carvacrol in two rat models of dementia. Behav Pharmacol 23:241-249.
4. Ba LA, Doring M, Jamier V, Jacob C (2010). Tellurium: an element with great biological potency and potential. Org Biomol Chem 8:4203-4216.
5. Beatty WW, Butters N, Janowsky DS (1986). Patterns of memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav Neural Biol 45:196-211.
6. Blokland A (1995). Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285-300.
7. Blokland A (1996). Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285-300.
8. Castellano C, Cestari V, Ciamei A (2001). NMDA receptors and learning and memory processes. Curr Drug Targets 2:273-283.
9. Comasseto JV, Menezes PH, Stefani HA, Zeni G, Braga AL (1996). Addition of hydrogen halides to acetylenic selenides. Synthesis of 1-halo-1- selenoalkenes. Tetrahedron 52:9687-9702.
10. Cunha RL, Gouvea IE, Juliano L (2009). A glimpse on biological activities of tellurium compounds. An Acad Bras Cienc 81:393-407.
11. Da Silva AL, Silva Martins B, Linck Vde M, Herrmann AP, Mai N, Nunes DS, et al. (2009). MK801- and scopolamine-induced amnesias are reversed by an Amazonian herbal locally used as a "brain tonic". Psychopharmacology (Berl) 202:165-172.
12. Ebert U, Kirch W (1998). Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28:944-949.
13. Gold PE (1986). The use of avoidance training in studies of modulation of memory storage. Behav Neural Biol 46:87-98.
14. Graef S, Schonknecht P, Sabri O, Hegerl U (2011). Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings. Psychopharmacology (Berl) 215:205-229.
15. Gsell W, Jungkunz G, Riederer P (2004). Functional neurochemistry of Alzheimer's disease. Curr Pharm Des 10:265-293.
16. Gupta R, Gupta LK (2012). Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease. Pharmacol Biochem Behav 102:184-190.
17. Hasselmo ME (2006). The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16:710-715.
18. Hasselmo ME, McGaughy J (2004). High acetylcholine sets circuit dynamics for attention and encoding: low acetylcholine sets dynamics for consolidation. Prog Brain Res 145:207-231.
19. Izquierdo I (1989). Different forms of posttraining memory processing. Behav Neural Biol 51:171-202.
20. Klinkenberg I, Blokland A (2010). The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34:1307-1350.
21. Klinkenberg I, Blokland A (2011). A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology (Berl) 215:549-566.
22. Klinkenberg I, Sambeth A, Blokland A (2010). Acetylcholine and attention. Behav Brain Res 221:430-442.
23. Mattson MP (2004). Pathways towards and away from Alzheimer's disease. Nature 430:631-639.
24. Mattson MP (2008). Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci 1144:97-112.
25. McGaugh JL, Izquierdo I (2000). The contribution of pharmacology to research on the mechanisms of memory formation. Trends Pharmacol Sci 21: 208-210.
26. Mesulam M (2004). The Cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11:43-49.
27. Morris RG (1984). Development of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
28. Okun E, Arumugam TV, Tang SC, Gleichmann M, Albeck M, Sredni B, et al. (2007). The organotellurium compound ammonium trichloro(dioxoethyleneo, o0) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J Neurochem 102:1232-1241.
29. Pakpour B, Ahmadi S, Nayer-Nouri T, Oryan S, Zarrindast MR (2010). Inhibitory avoidance memory deficit induced by scopolamine: interaction with glutamatergic system in the nucleus accumbens. Behav Pharmacol 21: 719-726.
30. Persike DS, RL Cunha, Juliano L, Silva IR, Rosim FE, Vignolli T, et al. (2008). Protective effect of the organotellurane RT-07 in pilocarpine-induced status epilepticus. Neurobiol Dis 31:120-126.
31. Power AE, Vazdarjanova A, McGaugh JL (2003). Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80:178-193.
32. Rusted JM, Warburton DM (1988). The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) 96:145-152.
33. Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E (2006). Effects of systemic administration of b-casomorphin-5 on learning and memory in mice. Eur J Pharmacol 530:81-87.
34. Sarter M, Bruno JP (1997). Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23:28-46.
35. Souza ACG, Luchese C, Neto JSS, Nogueira CW (2009). Antioxidant effect of a novel class of telluroacetilene compounds: studies in vitro and in vivo. Life Sci 84:351-357.
36. Souza ACG, Acker CI, Gai BM, Neto JSS, Nogueira CW (2012). 2-Phenylethynyl-butyltellurium improves memory in mice. Neurochem Int 60:409-414.
37. Souza ACG, Sari MHM, Pinton S, Luchese C, Neto JSS, Nogueira CW (2013). 2-Phenylethynyl-butyltellurium attenuates amyloid beta peptide(25-35)-induced learning and memory impairments in mice. J Neurosci Res 91:848-853.
38. Sredni B (2012). Immunomodulating tellurium compounds as anti-cancer agents. Semin Cancer Biol 22:60-69.
39. Tiekink ER (2012). Therapeutic potential of selenium and tellurium compounds: opportunities yet unrealised. Dalton Trans 41:6390-6395.
40. Urig S, Becker K (2006). On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol 16:452-465.
41. Walsh RN, Cummins RA (1976). The open-field test: a critical review. Psychol Bull 83:482-504.
42. Weinberger NM (2006). Food for thought: honeybee foraging, memory, and acetylcholine. Sci STKE 336:1-3.
43. Wieslander E, Engman L, Svensjo E, Erlansson M, Johansson U, Linden M, et al. (1998). Antioxidative properties of organotellurium compounds in cell systems. Biochem Pharmacol 55:573-584.